Kazia Therapeutics Limited

CANTRIXIL

Pharmaceutical preparations for treating cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for treating cancer for human use; pharmaceutical products for treating cancer; pharmaceutical compounds for treating cancer; chemical preparations for pharmaceutical purposes, namely, for treating cancer; chemical preparations for treating cancer; diagnostic preparations for medical purposes;

KAZIA

Pharmaceutical preparations, namely, cytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human use, namely, pharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposes;Chemicals used in science; chemicals for use in the manufacture of pharmaceuticals and medicine; biochemicals, namely, precursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticals;The wording KAZIA has no meaning in a foreign language.;Scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticals, namely, scientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services;

KAZIA THERAPEUTICS

Pharmaceutical preparations, namely, cytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human use, namely, pharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposes;Chemicals used in science; chemical products for use in the manufacture of pharmaceuticals and medicine; biochemicals, namely, precursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticals;The wording KAZIA has no meaning in a foreign language.;THERAPEUTICS;Scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticals, namely, scientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services;